April 14, 2021
Business News

Jabil Healthcare Signs Strategic Collaboration Agreement with E3D, Expanding Pharmaceutical Market Offering

ST. PETERSBURG, Fla.–()–Jabil Healthcare, a division of Jabil Inc. (NYSE: JBL), today announced it has entered a strategic collaboration agreement with global drug delivery device company E3D, a member of the Elcam Medical Group, which gives Jabil access to E3D’s reusable mechanical auto-injector. Under the terms of this deal, Jabil has secured exclusive rights to develop a high-volume reusable auto-injector and connected variants.

The agreement enables Jabil Healthcare to further develop connected auto-injectors for a range of dosing volumes and patient-centric benefits, ultimately creating a platform of devices. Jabil Healthcare applies its expertise to help customers through the design, development and…

Click here to view the original article.

Related Posts

You might also like ...

Samsung Introduces PixCell LED for Intelligent Headlight Systems to Enhance Road Safety
AON Splash Image
GenScript Biotech BV e IES Diagnostics concludono accordo di distribuzione per il kit per anticorpi anti-SARS-CoV-2
Arctos NorthStar Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing April 15, 2021